Oxothiazolidine carboxylate
Alternative Names: OTC; OTZ; ProcysteineLatest Information Update: 24 Oct 2021
At a glance
- Originator Nonindustrial source
- Developer Nonindustrial source; Transcend Therapeutics [CEASED]
- Class Reducing agents; Small molecules
- Mechanism of Action Glutathione synthase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Adult respiratory distress syndrome; Amyotrophic lateral sclerosis; Atherosclerosis; Cardiovascular disorders; Dermatitis; HIV-1 infections; Multiple organ failure
Most Recent Events
- 18 Jun 2001 No-Development-Reported for Amyotrophic lateral sclerosis in USA (IV)
- 18 Jun 2001 No-Development-Reported for Amyotrophic lateral sclerosis in USA (PO)
- 18 Jun 2001 No-Development-Reported for Multiple organ failure in Canada (Unknown route)